Dermaliq Therapeutics
Dermaliq Therapeutics, Inc. is uniquely positioned to revolutionize topical dermatology. With our proprietary hyliQ® technology platform, we are breaking through traditional delivery barriers, enabling for the first time the targeted absorption into skin structures with unmatched bioavailability and cutaneous tolerability. This breakthrough paves the way for first-in-class and best-in-class topical treatments with broad application across dermatology and rare disease indications, offering substantial opportunities for long-term growth and value creation.Dermaliq’s pipeline includes clinical stage assets in androgenetic alopecia, alopecia areata and wound healing.Content by Dermaliq Therapeutics
| 2 min read
Dermaliq’s proprietary hyliQ® technology platform enables touchless delivery of novel drug therapies to fragile, sensitive or disease-affected skin.
Page 1 of 1 - 1 Total Items
